PTS Pulse – Page 8 – PTS Diagnostics

0

PTS Diagnostics Announces Jonathan Chapman as President and Chief Executive Officer

Effective immediately, adds proven record of global leadership and demonstrated success

WHITESTOWN, Ind. (March 24, 2020) – PTS Diagnostics, a U.S.-based manufacturer of point-of-care medical testing devices announced today that Jonathan Chapman has been appointed as President and Chief Executive Officer.

Mr. Chapman brings 20 years of leadership experience in the medical device industry, most recently serving as President of ARKRAY USA, Inc. He joins PTS Diagnostics with an accomplished track record regarding mergers and acquisitions, post-acquisition integration, global product launches, market identification, and strategic positioning.

“I’m honored to join the PTS Diagnostics team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes and assessment of cardiovascular disease risk,” said Jonathan Chapman, President and CEO of PTS Diagnostics. “We will continue our legacy of bringing leading innovation to patients across the globe. PTS Diagnostics’ broad capabilities, world-class leadership team, and committed people give me great confidence about our future.”

Mr. Chapman received a Bachelor of Arts from Sheffield University UK, LLM Commercial and Corporate Law from University of London (SOAS) and LLM Health Law from Hamline Law School, St. Paul, MN. PTS Diagnostics is confident that his international experience will be immensely valuable when leading the organization across global markets.

Mr. Chapman will be based out of the Whitestown, Ind. global headquarters.

As a comprehensive point-of-care diagnostics company, PTS Diagnostics manufactures solutions that close gaps in care for patients with chronic conditions such as diabetes, cardiovascular disease, and other related comorbidities.

For more information about PTS Diagnostics and the executive leadership team, please visit ptsdiagnostics.com,
call 877-870-5610, or reference the press contact information below.

About PTS Diagnostics

Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

Press Contact

Ryan Simpson, Marketing Communications
317-870-5610 – rsimpson@ptsdiagnostics.com

0

March 23. 2020

by Website Adminin Press Release

PTS Diagnostics Announces A1CNow+ Controls™

Refrigerated storage up to 8 months, initially available in U.S., Europe

WHITESTOWN, Ind. (March 23, 2020) – PTS Diagnostics, a U.S.-based manufacturer of point-of-care medical testing devices announced today that they are launching A1CNow+ Controls for the A1CNow®+ Test System.

Initially available in the United States, European Union, and the United Kingdom, A1CNow+ Controls can be stored frozen for up to three years, refrigerated for eight months, or at room temperature for seven days. Intended to ensure accurate A1C results, the solution comes with two levels, each in a dropper style vial and can be successfully run in minutes.

“PTS Diagnostics-branded controls ensure that our customers have access to a high-quality solution that meets our stringent regulatory guidelines,” said Mark Duncan, Director, Global Product Management. “We are excited to provide benefits such as easy-to-use dropper style vials and extended shelf life.”

For additional information about the product, reference the A1CNow+ Controls webpage. Please call customer service at 317-870-5610 (direct) or 877-870-5610 (toll-free US only) with any questions. Connect with your local distribution partner if you are interested in purchasing A1CNow+ Controls or any other product. Find them via PTS Diagnostics Distributors.

About PTS Diagnostics

Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.